119 related articles for article (PubMed ID: 25087672)
1. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract][Full Text] [Related]
2. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
[TBL] [Abstract][Full Text] [Related]
3. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
Singh I; Gautam L
J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
[No Abstract] [Full Text] [Related]
4. Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
Ravi P; Sammon J; Meskawi M; Sun M; Karakiewicz PI; Trinh QD
J Urol; 2012 Aug; 188(2):677-8. PubMed ID: 22704450
[No Abstract] [Full Text] [Related]
5. Complications after prostate biopsy: data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
[TBL] [Abstract][Full Text] [Related]
6. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
Horan AH
J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
[No Abstract] [Full Text] [Related]
7. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
8. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
Kibel AS
J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
[No Abstract] [Full Text] [Related]
9. Reply by authors.
J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
[No Abstract] [Full Text] [Related]
10. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.
Loeb S; Walter D; Curnyn C; Gold HT; Lepor H; Makarov DV
J Urol; 2016 Sep; 196(3):721-6. PubMed ID: 26946161
[TBL] [Abstract][Full Text] [Related]
11. Reply by author.
J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
[No Abstract] [Full Text] [Related]
12. Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.
Chamberland RR
J Clin Microbiol; 2016 Oct; 54(10):2431-5. PubMed ID: 27147719
[TBL] [Abstract][Full Text] [Related]
13. Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis.
Halpern JA; Sedrakyan A; Dinerman B; Hsu WC; Mao J; Hu JC
J Urol; 2017 Apr; 197(4):1020-1025. PubMed ID: 27856226
[TBL] [Abstract][Full Text] [Related]
14. [Importance of repeat laterally directed sextant prostate biopsy for detection of prostate cancer in high-risk patients].
Vaiciūnas K; Auskalnis S; Matjosaitis A; Mickevicius A; Mickevicius R; Trumbeckas D; Jievaltas M
Medicina (Kaunas); 2007; 43(11):843-9. PubMed ID: 18084140
[TBL] [Abstract][Full Text] [Related]
15. Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.
Bokhorst LP; Lepistö I; Kakehi Y; Bangma CH; Pickles T; Valdagni R; Alberts AR; Semjonow A; Strölin P; Montesino MF; Berge V; Roobol MJ; Rannikko A
BJU Int; 2016 Sep; 118(3):366-71. PubMed ID: 26765682
[TBL] [Abstract][Full Text] [Related]
16. Commentary on: "Satisfaction with information used to choose prostate cancer treatment." Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Urology, Emory University, Atlanta, Georgia; Department of Urology, University of Michigan, Ann Arbor, Michigan; Department of Psychiatry and Public Health Institute, University of California-San Francisco, California; Institute for Public Policy and Social Research, Michigan State University, Lansing, Michigan; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; Department of Urology and Department of Health Policy and Management, University of California-Los Angeles, Los Angeles, California; Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.: J Urol 2014;191(5):1265-71. doi:10.1016/j.juro.2013.12.008. [Epub 2013 Dec 12].
Brent H
Urol Oncol; 2016 May; 34(5):247-8. PubMed ID: 25990613
[TBL] [Abstract][Full Text] [Related]
17. Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Chiu PK; Alberts AR; Venderbos LDF; Bangma CH; Roobol MJ
BJU Int; 2017 Sep; 120(3):394-400. PubMed ID: 28498624
[TBL] [Abstract][Full Text] [Related]
18. Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?
Dorin RP; Wiener S; Harris CD; Wagner JR
Prostate; 2015 May; 75(7):673-8. PubMed ID: 25597982
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Infection after Prostate Biopsy in the United States.
Shoag JE; Gaffney C; Pantuck M; Sun T; Gorin M; Schaeffer E; Sedrakyan A; Vickers A; Hu J
Urology; 2020 Apr; 138():113-118. PubMed ID: 31899233
[TBL] [Abstract][Full Text] [Related]
20. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
